CDC Reduces COVID-19 Quarantine Requirement
December 03, 2020

The CDC reduced the length of quarantine required for persons exposed to someone infected with SARS-CoV-2 from 14 days to 10 or to 7 with a negative test.

Baloxavir Marboxil Wins FDA Label Expansion for Post-exposure Flu Prevention
December 01, 2020

The expanded indication for baloxavir marboxil is positive news as the surge in US COVID-19 cases converges with the arrival of flu season.

6 Essential COVID-19 Codes to Remember
November 17, 2020

COVID-19 cases are surging across the country as the US heads into holiday season. Counsel patients on staying safe and keep these billing codes very close at hand.

Moderna COVID-19 Vaccine Candidate Achieves 94.5% Efficacy in Phase 3 Trial
November 16, 2020

Moderna announced safety and efficacy data from the phase 3 COVE trial that found mRNA-1273 94.5% effective in preventing infection with SARS-CoV-2.

COVID-19 is Not my First Epidemic
November 13, 2020

The author was a young medical student when the first signs of the HIV epidemic appeared and it shaped his career. How will COVID-19 impact today's young clinicians?

Influenza Coinfection with COVID-19: NIH Treatment Considerations
October 30, 2020

Recent NIH COVID-19 guideline updates include evidence-based considerations for treatment of patients hospitalized with flu and COVID-19 coinfection.

Hospitalized COVID-19 Patients Have More, More Severe Complications vs Patients with Influenza
October 23, 2020

The first study to compare COVID-19 and influenza complications in hospitalized patients found COVID-19 patients more likely to be admitted to ICU and to die.

NIH Updates Testing, Treatment Guidelines During Cocirculation of Influenza and COVID-19
October 22, 2020

The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.

The Presidential COVID-19 Treatment Regimen-to-date
October 06, 2020

From daily aspirin to RGN-CoV2 to zinc, the president of the United States has been treated for COVID-19 with a wide range of both authorized and unproven therapies.

Study: Antibiotic Prescription Durations for Common Infections Often Exceed Guidelines
October 05, 2020

Over half of antibiotic courses in a new study exceeded guideline-recommended minimum effective durations, translating to >54 million potentially excessive days.